Dr. Lingling Du, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
1514 Jefferson Hwy
New Orleans, LA 70121
Who else practices at this address →
Jefferson Parish includes primary care (18% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 184
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
LA license 304831 -
Student in an Organized Health Care Education/Training Program
MO license 2014011938 · OH license 57.019074
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ochsner Medical Center Acute New Orleans, LA
- Ochsner Medical Center - Baton Rouge Baton Rouge, LA
- Ochsner Medical Center-Kenner Kenner, LA
- Ochsner Medical Center-Hancock Bay Saint Louis, MS
- St Charles PArish Hospital Luling, LA
Medical groups
- Ochsner Clinic LLC (2,864 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 184
- Services billed
- 1,133
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 296 | 92 |
| Established patient office or other outpatient visit, 30-39 minutes | 136 | 83 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 33 | 13 |
| New patient office or other outpatient visit, 60-74 minutes | 32 | 32 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 20 | 19 |
| Hospital discharge day management, more than 30 minutes | 13 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ondansetron Odt (ondansetron) Other prescribers in New Orleans, LA | 75 |
| Oxycodone Hcl Other prescribers in New Orleans, LA | 51 |
| Eliquis (apixaban) Other prescribers in New Orleans, LA | 45 |
| Lidocaine-Prilocaine (lidocaine/prilocaine) Other prescribers in New Orleans, LA | 45 |
| Duloxetine Hcl Other prescribers in New Orleans, LA | 44 |
| Letrozole Other prescribers in New Orleans, LA | 43 |
| Olanzapine Other prescribers in New Orleans, LA | 40 |
| Promethazine Hcl Other prescribers in New Orleans, LA | 36 |
| Cyproheptadine Hcl Other prescribers in New Orleans, LA | 36 |
| Creon (lipase/protease/amylase) Other prescribers in New Orleans, LA | 30 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 134 payments worth $78,769 in total to this clinician.
| Exelixis Inc. | $35,754 |
|---|---|
| Boston Scientific Corporation | $33,998 |
| Sirtex Medical Inc | $4,548 |
| Beone Medicines USA, Inc. | $2,008 |
| Incyte Corporation | $1,100 |
| Eisai Inc. | $790 |
| Intera Oncology, Inc | $202 |
| AstraZeneca Pharmaceuticals LP | $181 |
| Compensation for services other than consulting (speaking, faculty) | $30,163 |
|---|---|
| Speaking at a medical education program | $27,073 |
| Travel and Lodging | $12,397 |
| Consulting Fee | $6,840 |
| Food and Beverage | $2,297 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Exelixis Inc. Dec 19, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $5,880 |
| Boston Scientific Corporation Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) General - Interventional Oncology · General - Interventional Oncology_PI | $5,688 |
| Exelixis Inc. Oct 7, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $4,410 |
| Exelixis Inc. Jun 11, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $3,430 |
| Exelixis Inc. May 28, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $3,430 |
| Exelixis Inc. Jul 8, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $3,308 |
| Sirtex Medical Inc Nov 11, 2025 | Consulting Fee SIR-Spheres Microspheres · Interventional Oncology | $3,000 |
| Exelixis Inc. Jul 1, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $2,940 |
| Boston Scientific Corporation Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | $2,600 |
| Boston Scientific Corporation Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI | $2,600 |
All 89 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Exelixis Inc. Dec 19, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $5,880 |
| Exelixis Inc. Dec 15, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Seattle, WA · in-kind | $185 |
| Exelixis Inc. Dec 15, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Seattle, WA · in-kind | $185 |
| Exelixis Inc. Dec 13, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Seattle, WA · in-kind | $176 |
| Exelixis Inc. Dec 13, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Seattle, WA · in-kind | $70.00 |
| Exelixis Inc. Dec 13, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Seattle, WA | $44.00 |
| Exelixis Inc. Dec 13, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Seattle, WA | $21.00 |
| Incyte Corporation Dec 5, 2025 | Consulting Fee ZYNYZ · Oncology | $1,100 |
| Exelixis Inc. Dec 1, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Flushing, NY | $0.01 |
| Exelixis Inc. Nov 24, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $1,470 |
| Boston Scientific Corporation Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) General - Interventional Oncology · General - Interventional Oncology_PI | $5,688 |
| Boston Scientific Corporation Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) General - Interventional Oncology · General - Interventional Oncology_PI | $1,000 |
| Boston Scientific Corporation Nov 13, 2025 | Travel and Lodging General - Interventional Oncology · General - Interventional Oncology_PI · travel to Maple Grove, MN | $60.00 |
| Sirtex Medical Inc Nov 11, 2025 | Consulting Fee SIR-Spheres Microspheres · Interventional Oncology | $3,000 |
| Sirtex Medical Inc Nov 11, 2025 | Travel and Lodging SIR-Spheres Microspheres · Interventional Oncology · travel to NEW ORLEANS, LA | $616 |
| Sirtex Medical Inc Nov 11, 2025 | Travel and Lodging SIR-Spheres Microspheres · Interventional Oncology · travel to NEW ORLEANS, LA | $496 |
| Sirtex Medical Inc Nov 11, 2025 | Travel and Lodging SIR-Spheres Microspheres · Interventional Oncology · travel to NEW ORLEANS, LA | $148 |
| Sirtex Medical Inc Nov 11, 2025 | Travel and Lodging SIR-Spheres Microspheres · Interventional Oncology · travel to NEW ORLEANS, LA | $8.00 |
| Exelixis Inc. Oct 8, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Seattle, WA · in-kind | $1,018 |
| Exelixis Inc. Oct 8, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Flushing, NY · in-kind | $288 |
| Exelixis Inc. Oct 7, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $4,410 |
| Exelixis Inc. Oct 6, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Flushing, NY · in-kind | $219 |
| Exelixis Inc. Oct 4, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Flushing, NY · in-kind | $622 |
| Exelixis Inc. Oct 4, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Flushing, NY · in-kind | $70.00 |
| Exelixis Inc. Oct 4, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Flushing, NY | $35.00 |
| Exelixis Inc. Oct 4, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Flushing, NY | $21.00 |
| Boston Scientific Corporation Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | $325 |
| Boston Scientific Corporation Sep 22, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI · travel to Maple Grove Weaver Lake, MN · in-kind | $226 |
| Boston Scientific Corporation Sep 22, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI · travel to Maple Grove Weaver Lake, MN · in-kind | $56.93 |
| Boston Scientific Corporation Sep 21, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI · travel to Maple Grove Weaver Lake, MN · in-kind | $617 |
| Boston Scientific Corporation Sep 21, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI · travel to Maple Grove Weaver Lake, MN · in-kind | $303 |
| Beone Medicines USA, Inc. Sep 17, 2025 | Consulting Fee | $1,950 |
| Boston Scientific Corporation Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI | $1,950 |
| Boston Scientific Corporation Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI | $975 |
| Boston Scientific Corporation Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI | $2,600 |
| Boston Scientific Corporation Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI | $1,300 |
| Boston Scientific Corporation Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI | $1,000 |
| Boston Scientific Corporation Jul 31, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI · travel to McAllen, TX | $217 |
| Boston Scientific Corporation Jul 31, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI · travel to McAllen, TX | $34.99 |
| Exelixis Inc. Jul 8, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $3,308 |
| Exelixis Inc. Jul 1, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $2,940 |
| Exelixis Inc. Jul 1, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $1,470 |
| Exelixis Inc. Jul 1, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Memphis, TN · in-kind | $366 |
| Exelixis Inc. Jul 1, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Hattiesburg, MS | $158 |
| Exelixis Inc. Jul 1, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Memphis, TN | $21.95 |
| Exelixis Inc. Jun 30, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Memphis, TN · in-kind | $180 |
| Exelixis Inc. Jun 30, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Memphis, TN · in-kind | $180 |
| Exelixis Inc. Jun 29, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Memphis, TN · in-kind | $70.00 |
| Exelixis Inc. Jun 29, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Memphis, TN · in-kind | $70.00 |
| Exelixis Inc. Jun 18, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Flushing, NY · in-kind | $542 |
| Exelixis Inc. Jun 11, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $3,430 |
| Exelixis Inc. Jun 1, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Dallas, TX | $58.51 |
| Exelixis Inc. Jun 1, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Dallas, TX | $46.94 |
| Exelixis Inc. May 28, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $3,430 |
| Exelixis Inc. May 26, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Dallas, TX · in-kind | $527 |
| Exelixis Inc. May 22, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Dallas, TX · in-kind | $70.00 |
| Exelixis Inc. May 22, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Dallas, TX · in-kind | $70.00 |
| Boston Scientific Corporation May 21, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI · travel to McAllen, TX · in-kind | $284 |
| Boston Scientific Corporation May 15, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | $1,950 |
| Boston Scientific Corporation May 15, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | $1,950 |
| Boston Scientific Corporation May 15, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | $1,950 |
| Boston Scientific Corporation May 15, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | $1,000 |
| Boston Scientific Corporation May 15, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | $975 |
| Boston Scientific Corporation May 15, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI · travel to Philadelphia, PA | $214 |
| Boston Scientific Corporation May 15, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI · travel to Philadelphia, PA | $56.27 |
| Exelixis Inc. May 8, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to San Antonio, TX · in-kind | $507 |
| Exelixis Inc. May 2, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to San Antonio, TX | $22.00 |
| Exelixis Inc. May 1, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to San Antonio, TX · in-kind | $70.00 |
| Exelixis Inc. May 1, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to San Antonio, TX · in-kind | $30.00 |
| Exelixis Inc. May 1, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to San Antonio, TX | $24.00 |
| Exelixis Inc. Apr 30, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Memphis, TN · in-kind | $255 |
| Exelixis Inc. Apr 30, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Memphis, TN · in-kind | $238 |
| Exelixis Inc. Apr 30, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Memphis, TN · in-kind | $82.22 |
| Exelixis Inc. Apr 25, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to San Antonio, TX · in-kind | $247 |
| Exelixis Inc. Apr 23, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Dallas, TX · in-kind | $421 |
| Exelixis Inc. Apr 23, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Dallas, TX · in-kind | $115 |
| Exelixis Inc. Apr 23, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to Dallas, TX · in-kind | $58.70 |
| Boston Scientific Corporation Apr 8, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI · travel to Philadelphia, PA · in-kind | $440 |
| Exelixis Inc. Apr 3, 2025 | Travel and Lodging CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid · travel to San Antonio, TX · in-kind | $545 |
| Eisai Inc. Mar 26, 2025 | Consulting Fee Lenvima · Oncology | $790 |
| Exelixis Inc. Mar 13, 2025 | Speaking at a medical education program CABOMETYX · Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid | $735 |
| Boston Scientific Corporation Jan 30, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI | $1,950 |
| Boston Scientific Corporation Jan 30, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI | $1,950 |
| Boston Scientific Corporation Jan 30, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI | $1,000 |
| Boston Scientific Corporation Jan 30, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI · travel to Atlantic City, NJ | $129 |
| Boston Scientific Corporation Jan 30, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI · travel to Atlantic City, NJ | $85.94 |
| Boston Scientific Corporation Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | $2,600 |
| Boston Scientific Corporation Jan 9, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI · travel to Atlantic City, NJ · in-kind | $299 |
| Boston Scientific Corporation Jan 8, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) · TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI · travel to Atlantic City, NJ · in-kind | $175 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 5 companies. The companies reported $324,901 in research payments for these studies, mostly to the institutions running them.
- TheraSphere With Durvalumab and Tremelimumab for HCC
Boston Scientific Corporation · Active, not recruiting · NCT05063565 - A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastat…
Janssen Research & Development, LLC - An openlabel multicenter randomized phase 3 study of firstline encorafenib plus cetuximab with or without chemotherapy versus standard of care therapy with a safety leadin of encorafenib and cetuximab plus chemotherap…
Pfizer Inc. - Atezolizumab and bevacizumab tiragolumab in 1L unresectable hcc pts
Genentech, Inc. - A Phase 3 Study, Open-label Randomized Trial of the Efficacy and Safety of Zanidatamab with Standard-of-Care Therapy Against Standard-of-Care Therapy Alone for Advanced HER2-positive Biliary Tract Cancer.
Jazz Pharmaceuticals Inc. - A phase 2B3 randomized doubleblind study to investigate the efficacy safety and tolerability of ponsegromab PF06946860 compared with placebo both with background firstline chemotherapy in adult participants with cache…
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.